Hims & Hers Health, Inc.
HIMS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $599 | $545 | $586 | $481 |
| % Growth | 9.9% | -7% | 21.8% | – |
| Cost of Goods Sold | $157 | $129 | $155 | $112 |
| Gross Profit | $442 | $416 | $431 | $370 |
| % Margin | 73.8% | 76.4% | 73.5% | 76.8% |
| R&D Expenses | $41 | $38 | $30 | $24 |
| G&A Expenses | $81 | $67 | $49 | $48 |
| SG&A Expenses | $313 | $285 | $280 | $269 |
| Sales & Mktg Exp. | $232 | $218 | $231 | $221 |
| Other Operating Expenses | $77 | $66 | $63 | $58 |
| Operating Expenses | $430 | $389 | $373 | $351 |
| Operating Income | $12 | $27 | $58 | $19 |
| % Margin | 2% | 4.9% | 9.9% | 3.9% |
| Other Income/Exp. Net | $0 | $6 | $3 | $4 |
| Pre-Tax Income | $12 | $33 | $60 | $22 |
| Tax Expense | $4 | -$10 | $11 | -$4 |
| Net Income | $16 | $43 | $49 | $26 |
| % Margin | 2.6% | 7.8% | 8.4% | 5.4% |
| EPS | 0.07 | 0.19 | 0.22 | 0.12 |
| % Growth | -63.2% | -13.6% | 83.3% | – |
| EPS Diluted | 0.06 | 0.17 | 0.2 | 0.11 |
| Weighted Avg Shares Out | 226 | 224 | 222 | 219 |
| Weighted Avg Shares Out Dil | 249 | 257 | 247 | 241 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $18 | $10 | $8 | $6 |
| EBITDA | $30 | $37 | $66 | $25 |
| % Margin | 5% | 6.8% | 11.3% | 5.1% |